ClinicalTrials.Veeva

Menu

Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"

Medical University of Vienna logo

Medical University of Vienna

Status

Enrolling

Conditions

Hemodynamic Monitoring
Pneumonia
ECMO Treatment
ARDS
Fluid Responsiveness
Intensive Care

Treatments

Device: Transthoracic Echocardiography
Device: Bioreactance
Drug: Fluid bolus
Diagnostic Test: Passive Leg Raising
Diagnostic Test: End-expiratory /-inspiratory occlusion test
Diagnostic Test: Vena Cava Ultrasound
Device: Uncalibrated Pulse Contour Analysis
Device: Transpulmonary Thermodilution/Calibrated Pulse Contour Analysis
Device: Esophageal Doppler

Study type

Interventional

Funder types

Other

Identifiers

NCT06593717
1612/2023

Details and patient eligibility

About

In extracorporeal membrane oxygenation (ECMO), blood is drawn out of the body via tubes, oxygenated in an artificial lung; and then pumped back into the blood vessels. This allows the supply of oxygen-rich blood to the organs (brain, heart, lungs, kidneys, liver, intestines, etc.) to be maintained.

Continuous monitoring of cardiac function and circulatory status (blood pressure, blood flow to organs) is very important in intensive care medicine in order to control the administration of circulation-supporting medication and infusions. Various devices are routinely used for this task. However, in the specific situation of ECMO treatment, the measurements of these devices could be affected due to the artificial circulation; outside the body.

The purpose of this study is therefore to test the accuracy of different methods of circulation monitoring during ECMO treatment.

Full description

Hemodynamic monitoring and tests for fluid responsiveness are cornerstones of intensive care medicine.

Generally, hemodynamic measurements can be obtained, for instance, with the following methods: pulmonary artery catheter, transthoracic echocardiography (TTE), esophageal doppler, transpulmonary thermodilution, pulse contour analysis and bioreactance, amongst others.

Maneuvers for assessing volume responsiveness include passive leg raising (PLR), respiratory pulse pressure variation (PPV), stroke volume variation (SVV), inferior vena cava ultrasound (IVC), and end-inspiratory or end-expiratory occlusion tests.

While these commonly used methods of hemodynamic assessment have been validated in various clinical scenarios, data are lacking in the setting of venovenous extracorporeal membrane oxygenation (VV ECMO). VV ECMO is commonly used for respiratory support in patients with severe acute respiratory failure. Blood is usually drained from a femoral vein, pumped through an oxygenator, where it is oxygenated and decarboxylated, and thereafter reinfused into the patient via a central venous, most commonly jugular, return cannula. Theoretically, the artificial circulation with its blood drainage and return flows may interfere with common hemodynamic monitoring techniques and lead to erroneous measurements.

The aim of this study therefore is to validate select techniques of hemodynamic monitoring and assessment of fluid responsiveness in patients on VV ECMO.

In the context of this study, the performance of different hemodynamic monitoring tools and techniques for predicting fluid responsiveness will be compared.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient receiving VV-ECMO support
  • Age 18 - 75 years

Exclusion criteria

  • Pregnancy
  • Conditions not allowing for passive leg raising maneuvers, e.g. "open abdomen", known or suspected elevation of intracranial pressure, recent leg or spinal trauma or orthopedic conditions not permitting leg raising
  • Known ischemic or hemorrhagic stroke within 3 months prior to study enrollment.

Suspicion of raised intracranial pressure is defined as pupil divergence (if not yet further clarified radiographically/neurologically/ophthalmologically) or signs detected in routine computed tomography scans (compressed or elapsed basal cisterns or midline shift > 5 mm.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Entire Study Population
Experimental group
Description:
The entire study population will undergo serial hemodynamic assessments throughout the course of ECMO therapy. Hemodynamic variables are obtained using transthoracic echocardiography, uncalibrated pulse contour analysis, and optionally - depending on device availability - transpulmonary thermodilution, bioreactance and esophageal doppler. Maneuvers for assessing volume responsiveness include passive leg raising (PLR), respiratory pulse pressure variation (PPV), stroke volume variation (SVV), inferior vena cava ultrasound (IVC), and end-inspiratory or end-expiratory occlusion tests.
Treatment:
Device: Esophageal Doppler
Device: Transpulmonary Thermodilution/Calibrated Pulse Contour Analysis
Diagnostic Test: Vena Cava Ultrasound
Device: Uncalibrated Pulse Contour Analysis
Diagnostic Test: End-expiratory /-inspiratory occlusion test
Diagnostic Test: Passive Leg Raising
Drug: Fluid bolus
Device: Bioreactance
Device: Transthoracic Echocardiography

Trial contacts and locations

1

Loading...

Central trial contact

Bernhard Nagler, MD; Thomas Staudinger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems